Speaker Profile
Ph.D., CEO and Co-Founder,
Biography
Sherine Chan leads Neuroene Therapeutics, a biotech company developing novel mitochondrial small-molecule therapies for difficult-to-treat neurological diseases, including pharmacoresistant epilepsies, Parkinsons disease, and those resulting from toxic exposures. Trained as a mitochondrial biologist, Dr. Chan previously served as an Associate Professor at the Medical University of South Carolina, where her academic lab developed new animal models and assays to study mitochondrial dysfunction. During this time, she co-founded Neuroene with medicinal chemist Dr. James Chou. Dr. Chan now leads Neuroene full-time from the Washington, DC region. Neuroene is as a JLABS and Blue Knight company, validating its CNS and medical countermeasure strategy.
Talk
Mitochondrial protective therapies for neurological diseases
This talk will present Neuroenes path from academic discovery to commercialization of patented mitochondrial therapies addressing a fundamental driver of neurological disease. We will discuss our dual-use approach, commitment to rigorous science and partnerships, and how this strategy can deliver new options for patients and caregivers facing diseases with limited effective treatments.
Emerging Therapeutics Showcase:
Neuroene Therapeutics Inc
Neuroene Therapeutics is an early-stage biotech company advancing first-in-class, brain-penetrant mitochondrial small-molecule therapies for severe neurological diseases with high unmet need, including drug-resistant epilepsy, Parkinson’s disease, and toxin-induced brain injury.
Session Abstract – PMWC 2026 Silicon Valley
The PMWC 2026 Emerging Therapeutics Showcase will provide a 15-30 minute time slot for selected companies and researchers in the CRISPR, Cell and Gene Therapy fields. Major advancements in safer cell- and gene-level editing technologies are bringing us closer toward cures for life-threatening disorders, from cancer to HIV to Huntington’s disease. Cell therapy, in which cellular material such as T cells capable of fighting cancer cells, is injected into a patient, has been demonstrated safe and effective. The popular new CRISPR tool that has been used to edit the genetic code of nearly any organism will have an enormous impact on human health. More than a dozen clinical trials employing CRISPR on human cells are already underway.
- Emerging Therapeutics/Cell Therapy
- Emerging Therapeutics/CVD
- Emerging Therapeutics/Gene Therapy
- Emerging Therapeutics/Immunotherapy
- Emerging Therapeutics/Radiation Therapy
